Survival of 51Cr-Labelled Autologous and Isologous Platelets as Differential Diagnostic Aid in Thrombocytopenic States


  • Arne Foss Abrahamsen M.D.

    Corresponding author
    1. Norsk Hydro's Institute for Cancer Research (Chief, R. Eker), The Norwegian Radium Hospital, Oslo
    2. Haematological Research Laboratory, Department IX (Chief, K. Aas), Ullevål University Hospital, Oslo, Norway
    Search for more papers by this author

The Norwegian Radium Hospital Montebello, Oslo 3, Norway


In 5 cases of hereditary thrombocytopathic thrombocytopenia, autologous platelets had a much shorter survival time than had isologous platelets. In 10 cases of acquired thrombocytopenia the survival of autologous and isologous platelets was almost identical. This different behaviours of autologous and isologous platelets thus seem to be specific for hereditary thrombocytopathias.